TheraScribe Essential 1.0 for Solo Practitioners: The Easy-to-Use Treatment Planning and Clinical Record Management System + The Addiction Treatment Planner Module (PracticePlanners)
Description:
TheraScribe Essential 1.0 is a flexible, cost-effective treatment planning and client record management system for the mental health professional working in a solo practice. Targeted to the busy therapist, TE 1.0 provides out-of-the-box functionality as well as nearly infinite expandability, to help users create a truly custom--and affordable--system that will meet the specific needs of their practice. TE 1.0 includes all of the key functions of TheraScribe 5.0, without the bells and whistles that are useful only to larger practices and advanced users. The basic package includes prewritten treatment planning language for one population--either adults, adolescents, children, or addicts. Users may purchase additional treatment planning modules for other populations, as well as progress note and homework modules to expand the functionality in their preferred areas. Therapists will find that TE 1.0 saves them time; speeds managed care reimbursement; allows them to create more effective treatment plans; and best of all frees up more time to spend with clients (or to use marketing their practice). Whether users opt for the basic package or choose to customize TE 1.0 for their unique practice, there is no more complete, flexible, and efficient system for treatment planning and client record management. Since it was first published in 1997, the Addiction Treatment Planner has become the established standard for writing effective and efficient treatment plans. Responding to the changing needs of the mental health community, this fully-revised resource offers new treatment planning language that is rooted in evidence based care, allowing practitioners to draft treatment plans that are grounded in the latest and most recognized treatments--and which meet the updated requirements of managed care companies and accrediting agencies. Other features include: Intervention language that follows the mandates of the American Society of Addiction Medicine (ASAM) which are being adopted at the state level across the US. Five new chapters covering issues such as Chronic Pain and Self-Care Deficits Flexible format which allows practitioners to choose easily between newer evidence based and traditional "best-practices" treatment approaches. New interventions that enable practitioners to track patient outcomes, by indicating when to re-test or re-assess using recognized assessment tools. Additional new interventions aimed at measuring patient satisfaction and perception of quality of care, as required by accrediting agencies.
Best prices to buy, sell, or rent ISBN 9780470097496
Frequently Asked Questions about TheraScribe Essential 1.0 for Solo Practitioners: The Easy-to-Use Treatment Planning and Clinical Record Management System + The Addiction Treatment Planner Module (PracticePlanners)
You can buy the TheraScribe Essential 1.0 for Solo Practitioners: The Easy-to-Use Treatment Planning and Clinical Record Management System + The Addiction Treatment Planner Module (PracticePlanners) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
If you’re interested in selling back the TheraScribe Essential 1.0 for Solo Practitioners: The Easy-to-Use Treatment Planning and Clinical Record Management System + The Addiction Treatment Planner Module (PracticePlanners) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the TheraScribe Essential 1.0 for Solo Practitioners: The Easy-to-Use Treatment Planning and Clinical Record Management System + The Addiction Treatment Planner Module (PracticePlanners) book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.